• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET Back to Search Results
Catalog Number 10310
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Anaphylactic Shock (1703); Tachycardia (2095); Reaction (2414)
Event Date 08/24/2019
Event Type  Injury  
Manufacturer Narrative
Investigation is in-process.A follow-up report will be provided.
 
Event Description
The customer reported that while undergoing continous mononuclear cell (cmnc) collection on spectra optia the gcsf mobilized donor experienced intense shivering, raised bp and fever.The donor also had tachycardia with heart beat rate at 110/min.Per physician's order, donor was administered i/v calcium gluconate, i/v avil, i/v paracetamol and i/v hydrocortisone 100 mg to manage the symptoms caused as a result of a reaction.Per the customer, the donor is reported as 'recovered' and in the stable condition.The exact incident date for this specific event is not known at this time.Donor identifier (id) : (b)(6).The spectra optia idl set is not available for return because it was discarded by the customer.
 
Event Description
The exact incident date for this specific event is reported accurately in the initial report.
 
Manufacturer Narrative
This report is being filed to provide in.Investigation: a review of the device history record (dhr) for this unit showed no irregularitiesduring manufacturing that were relevant to this issue.According to therapeutic apheresis: a physician's handbook, adverse events occur duringtherapeutic procedures with a frequency of 4.8%.Transient hypocalcemia associated withapheresis is ususally well tolerated.Symptoms often show as parasethesia (tingling) but patientsmay also experience unusual taste, nausea, lightheadedness, shivering, and tremors.Severehypocalcemia may also cause muscle contractions and can progress to tetany and seizures ifhypocalcemia escalates and is not corrected.Investigation is in-process.A follow-up report will be provided.
 
Manufacturer Narrative
This report is being filed to provide in investigation: the run data file (rdf) was analyzed for this event.No definitive root cause forthe reported adverse event could be identified from the rdf associated with this procedure.The system operated as intended and the procedure was run within standard operating limits (i.E.Not in ¿caution status¿).There were 48 ¿inlet pressure was too low¿ alarms in the procedure it lasted from 10:31-17:53,that means the patient was connected for more than 7 hours.1268ml of ac was delivered tothe patient over the course of the procedure.Access alarms alone are not known to cause adverse events but the excessive occurrence ofthem points toward issues with the patient access.The most common source of inlet pressurealarms is when the inlet flow rate is set too high for the given patient access, the patient access isoccluded/blocked, or the patient access is not properly positioned.Throughout the procedure the ac was returned at 0.8ml/min/ltbv to the patients.Nopotential sources of a patient reaction were identified.Root cause: a definitive root cause for the donor's reaction could not be determined.Possiblecauses include, but are not limited to ac management for the donor's physiology during theprocedure, the length of the procedure, and/or the donor's sensitivity to anticoagulant.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA IDL SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
MDR Report Key9099349
MDR Text Key163918336
Report Number1722028-2019-00277
Device Sequence Number1
Product Code GKT
UDI-Device Identifier05020583103108
UDI-Public05020583103108
Combination Product (y/n)N
PMA/PMN Number
BK150251
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup,Followup
Report Date 09/20/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/20/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/01/2021
Device Catalogue Number10310
Device Lot Number1903063131
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Manufacturer Received11/07/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age00031 YR
Patient Weight92
-
-